6-12

New Moderna Study Presents Robust Immune Response for 6-11 Year-olds After Covid-19 Vaccination

The American pharmaceutical company released data from a new study about the Covid-19 vaccine on children aged 6 to 11. The FDA,…

3 years ago

This website uses cookies.